Obesity Medicine Association

Welcome to Isle of Palms to those joining us for the OMA Summit 2024! Here's to a fantastic few days of learning, networking, and enjoying the beautiful coastal views. Don't forget to tag us in your photos! #OMASummit24 #ObesityMedicine #IsleofPalms

OMA extends its gratitude to seca for their support as a Gold Sponsor of OMA Summit 2024. seca’s commitment to delivering precision health tools is essential to advancing obesity medicine. Their support helps fuel impactful discussions and education at the Summit, empowering clinicians to provide the best care for women with obesity. Thank you, seca, for your continued partnership and dedication to precision in health care! #OMA #Obesity #OMASummit24

Each month, the OMA Pediatric Committee reviews key obesity-focused research to keep you informed on the latest developments. October’s update discusses the Global Surge of Type 2 Diabetes in Children and Adolescents. Read the full review at https://bit.ly/4h87zk5. #PediatricObesity #ObesityResearch #Diabetes #PediatricDiabetes #ObesityMedicine

The OMA thanks Currax Pharmaceuticals LLC for being a Platinum Sponsor of the OMA Summit 2024. Their generous support plays a vital role in advancing the education, collaboration, and treatment approaches that empower clinicians in addressing obesity. We are grateful for their commitment to the field of obesity medicine and to improving health outcomes for women with obesity. #OMA #Obesity #OMASummit24

Join the November Fundamentals of Obesity Treatment Course to enhance your clinical skills and knowledge. This accredited, evidence-based program covers the foundational knowledge surrounding obesity medicine so you can deliver comprehensive care to your patients. Whether you're preparing for board certification or seeking to advance your practice, this course provides the tools and strategies you need to succeed. Register today at https://bit.ly/3TQf7i8 #ObesityMedicine #OMA #FundamentalsofObesityTreatment

🔍 Understanding Menopause Weight Gain: The Science, Myths, and Solutions 🔍 https://lnkd.in/gHf-g82y Many women face unexpected weight gain during perimenopause and menopause, but it’s more complex than just diet and exercise. Hormonal changes, especially the drop in estrogen, play a significant role in how our bodies manage weight during this phase of life. In my latest episode of Fempower Health, I sit down with Dr. Angela Fitch MD, FACP, FOMA, Dipl. ABOM of knownwell and former president of the Obesity Medicine Association, to uncover the real science behind menopause weight gain. 🧠💡 Dr. Fitch shares: 🔅 How hormonal changes impact metabolism and appetite 🔅 Why small lifestyle changes aren’t always enough 🔅 The role of GLP-1 medications and other interventions in managing weight 🔅 How clinicians can better support women going through this stage If you’re a healthcare professional or a woman navigating perimenopause, this episode offers valuable, evidence-based insights into managing weight gain in a healthy, sustainable way. 🎧 Listen to the full episode where you listen to podcasts. #WomensHealth #MenopauseWeightGain #Perimenopause #Menopause #GLP1Medications #WeightManagement #FempowerHealth Lisa Larkin MD FACP NCMP Lauren Streicher MD James A. Simon MD

The Treat and Reduce Obesity Act (TROA) is gaining significant traction in Congress, marking the most progress it's seen since its introduction 12 years ago. With momentum building, there is real potential for the legislation to pass this year. During recent meetings with Congressional staff, we were strongly encouraged to maintain advocacy efforts, particularly by having healthcare providers reach out to members of Congress. Your voice can make a critical difference. We invite you to learn more about TROA and send an editable, pre-written letter to your representatives. Personalizing your letter with details about how the lack of comprehensive care coverage affects your patients will strengthen the message. Take action and learn more today at: https://bit.ly/4h4Ht18 #Obesity #TROA #ObesityAdvocacy

As of October 1, new ICD-10 codes for obesity treatment are available! These codes represent a major step forward in ensuring accurate diagnosis and personalized care for patients with obesity. Clinicians can now leverage these advancements to better track patient outcomes and improve care strategies. Learn more about these updates at https://bit.ly/485exSz #OMA #Obesity #ICD10 #ICD10Codes #BillingandCoding

Yesterday, the Congressional Budget Office released its report, “How Would Authorizing Medicare to Cover Anti-Obesity Medications Affect the Federal Budget?” We appreciate the CBO’s important addition to the conversation around increasing access to obesity treatment for Medicare beneficiaries and the work that went into their cost estimate. However, we are disappointed that the report does not address the expansion of intensive behavioral therapy and, therefore, the potential for additional cost savings. Ensuring access to obesity care is critical for improving health outcomes and reducing long-term healthcare costs. On behalf of the millions of older Americans living with obesity, the Obesity Care Advocacy Network (OCAN) will continue to advocate for increased access to treatments and care. Please see below for our complete statement. https://lnkd.in/eZ4UbRDm

Join American Medical Association and OMA on Oct. 17 at 11 a.m. CT to gain insights into the intersection of #obesity and #hypertension as well as strategies to address these conditions. The conversation will be led by OMA President-Elect and Chief Science Officer, Dr. Harold Bays! Register now at https://bit.ly/401DNXZ #OMA #ObesityMedicine